$301.66
Currently 21 wall-street analysts regularly analyze the financials of Madrigal Pharmaceuticals, Inc. on a frequent basis to provide recommendations along with target share price. 21 analysts offering 12-month price forecasts for Madrigal Pharmaceuticals, Inc. (MDGL) have a share price target of $414.07. This median of share price forecast represents a 37.26% upside from the latest price of $301.66 as on 19.04.25.
As per the chart shown above, analysts believe that the Madrigal Pharmaceuticals, Inc. (MDGL) share price will touch around $414.07 in next 12-months.
Below is a chart showing the percentage difference between Madrigal Pharmaceuticals, Inc.'s share price and its median forecast price. As on 19.04.25, the difference is -21.76%
Based on 21 analysts tracking and researching Madrigal Pharmaceuticals, Inc. (MDGL) share have buy recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 11 | 11 | 11 |
Outperform | 5 | 6 | 6 |
Hold | 3 | 3 | 3 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 1 |